Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients

References

• Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Euro J Cancer. 2001;37(8):4–66. doi:10.1016/S0959-8049(01)00267-2.
   PubMed Web of Science ®Google Scholar
• Minna JD. Neoplasms of the lung. In: Fauci AS, Braunwald E, Isselbacher KJ, et al., editors. Harrison's princiles of international medicine. New York: McGraw Hill; 1998. p. 552–562.
   Google Scholar
• Sekido Y, Kwun M, Minna JD. Progress in understanding the molecular pathogenesis of human lung cancer. Biophys Acta (BBA)-Rev Cancer. 1998;1378:F21–F59. doi:10.1016/S0304-419X(98)00010-9.
   PubMed Web of Science ®Google Scholar
• Morin PJ. ß-Catenin signalling and cancer. Bio Essays. 1999;21:1021–1030. doi:10.1002/(SICI)1521-1878(199912)22:1%3c1021::AID-BIES6%3e3.0.CO;2-P. PMID:10580987
   PubMed Web of Science ®Google Scholar
• Polakis P. Wnt signalling and cancer. Genes Development. 2000;14:1837–1851.
   PubMed Web of Science ®Google Scholar
• Uematsu K, He B, You L, et al. Activation of the Wnt pathway in non-small cell lung cancer: evidence of dishevelled overexpression. Oncogene. 2003;22:7218–7221. doi:10.1038/sj.onc.1206817. PMID:14562050
   PubMed Web of Science ®Google Scholar
• Sunaga N, Kohno T, Kolligs FT, et al. Constitutive activation of the Wnt signalling pathway by CTNNB1 (ß-Catenin) mutations in a subset of human lung adenocarcinoma. Genes, Chromosomes Cancer. 2001;20:316–321. doi:10.1002/1098-2264(2000)9999:9999%3c::AID-GCC1097%3e3.0.CO;2-9.
   Google Scholar
• Ueda M, Gemmill RM, West J, et al. Mutations of the β- and γ-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. British J Cancer. 2001;85:64–68. doi:10.1054/bjoc.2001.1863. PMID:11437403
   PubMed Web of Science ®Google Scholar
• Hommura F, Furuuchi K, Yamazaki K, et al. Increased expression of ß-catenin predicts better prognosis in nonsmall cell lung carcinomas. Cancer. 2002;94:752–758. doi:10.1002/cncr.10213. PMID:11857309
   PubMed Web of Science ®Google Scholar
• Winn RA, Bremnes RM, Bemis L, et al. Gamma-catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. Oncogene. 2002;21(49):7497–7506. doi:10.1038/sj.onc.1205963. PMID:12386812
   PubMed Web of Science ®Google Scholar
• Cleves H. Wnt/ß-Catenin signalling in development and disease. Cell. 2006;127:469–480. doi:10.1016/j.cell.2006.10.018. PMID:17081971
   PubMed Web of Science ®Google Scholar
• Katoh M. WNT/PCP signalling pathway and human cancer. Oncol Rep. 2005;1583–1588. PMID:16273260
   PubMedGoogle Scholar
• Veeman MT, Axelrod JD, Moon RT. A second canon: functions and mechanisms of ß-catenin-independent Wnt signalling. Development Cell. 2003;5:367–377. doi:10.1016/S1534-5807(03)00266-1. PMID:12967557
   PubMed Web of Science ®Google Scholar
• He B, You L, Uematsu K, et al. A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia. 2004;6:7–14. doi:10.1016/S1476-5586(04)80048-4. PMID:15068666
   PubMed Web of Science ®Google Scholar
• You L, He B, Uematsu K, et al. Inhibition of Wnt-1 signalling induces apoptosis in ß-catenin-deficient mesothelioma cells. Cancer Res. 2004;64:3474–3478. doi:10.1158/0008-5472.CAN-04-0115. PMID:15150100
   PubMed Web of Science ®Google Scholar
• Kawano Y, Kypta R. Secretad antagonists of the Wnt signalling pathway. J Cell Sci. 2003;116:2627–2634. doi:10.1242/jcs.00623. PMID:12775774
   PubMed Web of Science ®Google Scholar
• Hoang B, Moos M, Vukicevic S, et al. Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila Frizzled, suggest a role in skeletal morphogenesis. J Biol Chem. 1996;217:26131–26137. doi:10.1074/jbc.271.42.26131.
   Google Scholar
• Leyns L, Bouwmeester T, Kim S, et al. Frzb-1 is a secreted antagonist of Wnt signalling expressed in the Spemann organizer. Cell. 1997;88:747–756. doi:10.1016/S0092-8674(00)81921-2. PMID:9118218
   PubMed Web of Science ®Google Scholar
• Wang S, Krinks M, Lin K, et al. Frzb, a secreted protein expressed in the spemann organizer, binds and inhibits Wnt-8. Cell. 1997;88:757–766. doi:10.1016/S0092-8674(00)81922-4. PMID:9118219
   PubMed Web of Science ®Google Scholar
• Lin K, Wang S, Julius MA, et al. The cysteine-rich frizzled domain Frzb-1 is required and sufficient for modulation of Wnt signalling. Proc Natl Acad Sci. 1997;94:11196–11200. doi:10.1073/pnas.94.21.11196. PMID:9326585
   PubMed Web of Science ®Google Scholar
• Person AD, Garriock RJ, Krieg PA, et al. Frzb modulates Wnt-9a-mediated ß-catenin signalling during avian atrioventricular cardiac cushion development. Dev Biol. 2005;278:35–48. doi:10.1016/j.ydbio.2004.10.013. PMID:15649459
   PubMed Web of Science ®Google Scholar
• Lin Y, Shih Y, Lien G, et al. Promoter methylation of SFRP3 is frequent in hepatocellular carcinoma. Dis Markers. 2014; doi:10.1155/2014/351863.
   Web of Science ®Google Scholar
• Zi X, Guo Y, Simoneau AR, et al. Expression of Frzb/Secreted frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Cancer Res. 2005;65(21):9762–9770. doi:10.1158/0008-5472.CAN-05-0103. PMID:16266997
   PubMed Web of Science ®Google Scholar
• Qu Y, Li Y, Cai Q, et al. Over-expression of FRZB in gastric cancer cell suppresses proliferation and induces differentiation. J Cancer Res Clin Oncol. 2008;134:353–364. doi:10.1007/s00432-007-0291-0. PMID:17680269
   PubMed Web of Science ®Google Scholar
• Katoh M, Katoh M. Comparative genomics on SFRP2 orthologs. Oncol Rep. 2005;14(3):783–787. PMID:16077992
   PubMed Web of Science ®Google Scholar
• Gyorffy B, Surowiak P, Budczies J, et al. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoSOne. 2013;8:e82241. doi:10.1371/journal.pone.0082241. PMID:24367507
   PubMed Web of Science ®Google Scholar
• Veeck J, Chorovicer M, Naami A, et al. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation. Oncogene. 2008;27:865–876. doi:10.1038/sj.onc.1210669. PMID:17653090
   PubMed Web of Science ®Google Scholar
• Fink L, Seeger W, Ermert L, et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med. 1998;4:1329–1333. doi:10.1038/3327. PMID:9809560
   PubMed Web of Science ®Google Scholar
• Veeck J, Niederacher D, An H, et al. Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene. 2006;25:3479–3488. doi:10.1038/sj.onc.1209386. PMID:16449975
   PubMed Web of Science ®Google Scholar
• Noetzel E, Veeck J, Niederacher D, et al. Promoter methylation- associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer. BMC Cancer. 2008;8:154. doi:10.1186/1471-2407-8-154. PMID:18513385
   PubMed Web of Science ®Google Scholar
• Noetzel E, Rose M, Sevinc E, et al. Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse. Oncogene. 2010;29:4814–4825. doi:10.1038/onc.2010.229. PMID:20543860
   PubMed Web of Science ®Google Scholar
• Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe. 1987;8(3):138–140. PMID:3303008
   PubMed Web of Science ®Google Scholar
• Yuzugullu H, Benhaj K, Ozturk N, et al. Canonical Wnt signalling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Mol Cancer. 2009; 10.1186/1476-4598-8-90 doi:10.1186/1476-4598-8-90. PMID:19849855
   PubMed Web of Science ®Google Scholar
• Pourreyron C, Reilly L, Proby C, et al. Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed. PLOS One. 2012;7(2):e31827. doi:10.1371/journal.pone.0031827. PMID:22384081
   PubMed Web of Science ®Google Scholar
• Ekström EJ, Sherwood V, Andersson T. Methylation and loss of secreted frizzled-related protein 3 enhances melanoma cell migration and invasion. PLOS One. 2011;6(4):e18674. doi:10.1371/journal.pone.0018674. PMID:21494614
   PubMed Web of Science ®Google Scholar
• Mazieres J, He B, You L, et al. Wnt signalling in lung cancer. Cancer Lett. 2005;222(1):1–10. doi:10.1016/j.canlet.2004.08.040. PMID:15837535
   PubMed Web of Science ®Google Scholar
• Marsit CJ, Houseman EA, Christensen BC, et al. Indentification of methylated genes associated with aggressive bladder cancer. PLoS One. 2010;5.
   Web of Science ®Google Scholar
• Mori M, Rao SK, Popper HH, et al. Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung. Mod Pathol. 2001;14(2):72–84. doi:10.1038/modpathol.3880259. PMID:11235908
   PubMed Web of Science ®Google Scholar
• McRonald FE, Morris MR, Gentle D, et al. CpG methylation profiling in VHL unrelated renal cell carcinoma. Mol Cancer. 2009;8:31. doi:10.1186/1476-4598-8-31. PMID:19493342
   PubMed Web of Science ®Google Scholar
• Kongham PN, Northcott PA, Croul SE, et al. The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma. Oncogene. 2010;29:3017–3024. doi:10.1038/onc.2010.32. PMID:20208569
   PubMed Web of Science ®Google Scholar
• Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a ßcatenin-Tcf complex in APC-/- colon carcinoma. Science. 1997;275:1784–1787. doi:10.1126/science.275.5307.1784. PMID:9065401
   PubMed Web of Science ®Google Scholar
• Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the ß-catenin/LEF-1 pathway. Proc Nat Acad Sci United States Am. 1998;96:5522–5527. doi:10.1073/pnas.96.10.5522.
   Web of Science ®Google Scholar
• Tetsu O, McCormick F. ß_catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422–426. doi:10.1038/18884. PMID:10201372
   PubMed Web of Science ®Google Scholar
• Mizushima T, Nakagawa H, Kamberov YG, et al. Wnt-1 but not epidermal growth factor induces ß-catenin/T-cell factor-dependent transcription in esophageal cancer cells. Cancer Res. 2002;62:277–282. PMID:11782388
   PubMed Web of Science ®Google Scholar
• Nakashima T, Liu D, Nakano J, et al. Wnt1 overexpression associated with tumor proliferation and a poor prognosis in non-small cell lung cancer patients. Oncol Rep. 2008;19:203–209. PMID:18097596
   PubMed Web of Science ®Google Scholar
• Tetsu O, McCormick F. ß-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Lett Nat. 1999;398:422–426. doi:10.1038/18884.
   PubMed Web of Science ®Google Scholar
• Connell-Crowley L, Harper JW, Goodrich DW. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol Biol Cell. 1997;8(2):287–301. doi:10.1091/mbc.8.2.287. PMID:9190208
   PubMed Web of Science ®Google Scholar
• Stacey DW. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Current Opinion Cell Biol. 2003;15(2):158–163. doi:10.1016/S0955-0674(03)00008-5. PMID:12648671
   PubMed Web of Science ®Google Scholar